FPR2 and neoplasm: For example, neutrophils and NK cells showed significant interactions with tumour cells through pathways such as MIF‐(CD74 + CXCR4) and ANNEXIN‐(FPR1 + FPR2), which are known to modulate immune responses and tumour progression.